Antimicrobial resistance (AMR) has and continues to pose both development & public health threats across the world. While the scourge is well disseminated globally, persons living in low- & middle-income countries (LMICs) are most at risk. In Kenya, AMR represents a pivotal driver of morbidity & mortality as infections that are resistant to antibiotics have continued to rise lately. Empirical data on the state of AMR in Kenya and other LMICs is conspicuously low or completely lacking. This has significantly muffled intervention strategies as explicit understanding of AMR faculties remains a bottleneck. We conducted a scoping review to understand the nexus between practice of ethical principles of biomedicine & occurrence of AMR. PRISMA guidelines were strictly referenced at every step of this review. PubMed, EMBASE & Cochrane databases were searched using google for relevant articles. A total of 187 articles were initially generated. Several filters were applied in order to develop a shortlist of the most relevant articles. They include: conformity to the stated study objective & research design, publication in highly refereed journal type, consistency with medical subject headings (MeSh) and lack of potential conflict of interest (CoI). Finally, a total of 5 articles were identified and the results they represent well synthesized. Balancing provisions of the practice of ethical principles of biomedicine by clinicians & other critical players remains an important challenge. A prescription & practice model that considers a balance of provisions of the four ethical principles of biomedicine should be developed and implemented. Empirical research should be continuously conducted to generate updated knowledge that informs progressive policy formulation and development of effective intervention strategies.
Tripathi SP, Borgaonkar D, Kerkar PG. Preantibiotic era revisited: Janeway’s lesions and Osler’s nodes. European Heart Journal. 2002: 37(25).
Aminov IA. Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future. Front Microbiol. 2010; 1: 134.
Padiyara P, Inoue H, Sprenger M. Global Governance Mechanisms to Address Antimicrobial Resistance. Infectious Diseases: Research and Treatment, 2018: 11: 117863371876788.
Wismandanu O. Antimicrobial Resistance, How Should We Act? Hacked by DKad0x. 2016; 1(1).
Meilan S. Drug-Resistant Infections Could Kill 10 million People Annually by 2050. Smithsonianmag.Com. 2019.
Center for Disease Control & Prevention. Biggest Threats and Data. [Internet] 2021 Available from: https://www.cdc.gov/drugresistance/biggest-threats.html.
Vesper I. Antimicrobial resistance: facts and figures. Sci Dev Net. [Internet] 2019 Available from: https://www.scidev.net/sub-saharan africa/features/antimicrobial-resistance-facts-and-figures-1/
Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ et al. Executive summary: Implementing an antibiotic stewardship program: Guidelines by the infectious diseases’ society of America and the society for healthcare epidemiology of America. Clinical Infectious Diseases. 2016: 62(10): 1197–1202.
World Bank. Drug-Resistant Infections: A Threat to Our Economic Future. World Bank Report, 2016: 1–132.
Moak K. The 2008 Global Financial Crisis: Effects on the Global Economy. In Developed Nations and the Economic Impact of Globalization. 2017: 167–187.
Thomas McCormick, D. Min. Bioethics Tools: Principles of Bioethics. Ethics in Medicine, Senior Lecturer Emeritus, Dept. Bioethics and Humanities, School of Medicine, University of Washington, 2009: 1–29.
Embrey M. Ensuring good dispensing practices. Managing Access to Medicines and Health Technologies, 2012: 28–45.
Rusic D, Bozic J, Bukic J, Vilovic M, Tomicic M, Seselja PA, et al. Antimicrobial Resistance: Physicians’ and Pharmacists’ Perspective. Microbial Drug Resistance. 2020.
Wesangula D. How pharmacies are putting lives of patients in danger. Home/Health & Science. 2020.
Villasís KM, Rendón MM, García H, Miranda NM, Escamilla NA. Systematic review and meta-analysis as a support tool for research and clinical practice. Revista Alergia Mexico, 2020: 67(1): 62–72.
Gordon G, Andrew DO, Elie AA, Regina K, Gunn V, Jan BR et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64(4): 383-94.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021: 372.
Parsonage B, Hagglund PK, Keogh L, Wheelhouse N, Brown RE, Dancer SJ. Control of antimicrobial resistance requires an ethical approach. Frontiers in Microbiology. 2017: 8: 1–14.
Littmann J, Viens AM, Silva DS. The Super-Wicked Problem of Antimicrobial Resistance. 2020.
Leonard L, Micah P and Ovadia E. Ethical dilemmas in antibiotic treatment. Journal of Antimicrobial Chemotherapy. 2012: 67(1): 12-16.
Anomaly J. Ethics, Antibiotics, and Public Policy. 2017: 999–1015.
Jasper L, Annette R, Alena B. Tackling anti-microbial resistance: ethical framework for rational antibiotic use. European Journal of Public Health. 2018: 28(2): 359–363.
This work is licensed under a Creative Commons Attribution 4.0 International License.